1st Quarter - Report

DAVIDSON & COMPANY for CBS CORPORATION

Period 1st Quarter 2008 Filed Apr 15, 2008 Signed by Karen Blitz, Office Manager

Official filing
Firm
DAVIDSON & COMPANY
Client
CBS CORPORATION
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Advertising ADV

S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act

LobbyistCovered position, as disclosed
JAMES H DAVIDSON —

Bills named: H.R. 4083 (110th), S. 334 (110th), S. 484 (110th), S. 2311 (110th), S. 468 (110th), H.R. 1561 (110th), H.R. 2117 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.